Establishment Labs Holdings PE Ratio 2017-2024 | ESTA

Current and historical p/e ratio for Establishment Labs Holdings (ESTA) from 2017 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Establishment Labs Holdings PE ratio as of June 24, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Establishment Labs Holdings PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-06-25 44.53 0.00
2024-03-31 50.90 $-3.14 0.00
2023-12-31 25.89 $-3.04 0.00
2023-09-30 49.07 $-2.80 0.00
2023-06-30 68.61 $-2.44 0.00
2023-03-31 67.74 $-3.31 0.00
2022-12-31 65.65 $-3.42 0.00
2022-09-30 54.61 $-3.48 0.00
2022-06-30 54.38 $-2.94 0.00
2021-12-31 67.59 $-1.71 0.00
2021-09-30 71.58 $-1.35 0.00
2021-06-30 87.34 $-0.98 0.00
2021-03-31 62.53 $-0.94 0.00
2020-12-31 37.64 $-1.10 0.00
2022-03-31 67.39 $-1.66 0.00
2020-09-30 18.53 $-1.69 0.00
2020-06-30 18.68 $-2.13 0.00
2020-03-31 14.45 $-2.12 0.00
2019-12-31 27.66 $-1.86 0.00
2019-09-30 18.91 $-2.11 0.00
2019-06-30 21.99 $-1.43 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $1.226B $0.165B
Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its technologies portfolio includes Divina 3D Simulation System(R), Puregraft and MotivaImagine Centers (R). Establishment Labs Holdings Inc. is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $125.903B 15.80
Cencora (COR) United States $47.741B 18.61
ICON (ICLR) Ireland $26.139B 24.68
DiDi Global (DIDIY) China $21.386B 0.00
Avantor (AVTR) United States $15.283B 22.50
CochLear (CHEOY) Australia $14.173B 0.00
Revvity (RVTY) United States $13.191B 23.14
Natera (NTRA) United States $13.190B 0.00
Medpace Holdings (MEDP) United States $12.644B 41.60
Viatris (VTRS) United States $12.466B 3.73
Charles River Laboratories (CRL) United States $10.809B 20.69
EUROFINS SCIENT (ERFSF) Luxembourg $9.137B 0.00
Solventum (SOLV) United States $8.860B 0.00
Sonic Healthcare (SKHHY) Australia $8.681B 0.00
HealthEquity (HQY) United States $7.198B 46.21
Organon (OGN) United States $5.431B 5.15
Bausch + Lomb (BLCO) Canada $5.256B 21.04
Doximity (DOCS) United States $5.107B 35.77
PACS (PACS) United States $4.437B 0.00
Life Times (LTH) United States $3.623B 37.96
Sotera Health (SHC) United States $3.369B 16.53
Surgery Partners (SGRY) United States $3.017B 27.60
GoodRx Holdings (GDRX) United States $2.859B 108.86
Agilon Health (AGL) United States $2.677B 0.00
Progyny (PGNY) United States $2.487B 42.82
AMN Healthcare Services Inc (AMN) United States $2.029B 8.04
NovoCure (NVCR) Jersey $2.014B 0.00
Premier (PINC) United States $1.949B 8.34
BrightSpring Health Services (BTSG) United States $1.852B 0.00
Teladoc Health (TDOC) United States $1.757B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.566B 0.00
Alignment Healthcare (ALHC) United States $1.449B 0.00
CareDx (CDNA) United States $0.749B 0.00
Embecta (EMBC) United States $0.722B 4.91
GeneDx Holdings (WGS) United States $0.717B 0.00
InnovAge Holding (INNV) United States $0.695B 0.00
Pediatrix Medical (MD) United States $0.680B 7.21
Auna S.A (AUNA) Luxembourg $0.568B 0.00
Sharecare (SHCR) United States $0.497B 0.00
QDM (QDMI) Hong Kong, SAR China $0.437B 11.45
COMPASS Pathways (CMPS) United Kingdom $0.430B 0.00
Enhabit (EHAB) United States $0.426B 42.50
ModivCare (MODV) United States $0.367B 6.87
Sonida Senior Living (SNDA) United States $0.345B 0.00
DocGo (DCGO) United States $0.310B 16.94
LifeMD (LFMD) United States $0.288B 0.00
MultiPlan (MPLN) United States $0.238B 0.00
Beauty Health (SKIN) United States $0.223B 0.00
Sera Prognostics (SERA) United States $0.212B 0.00
Ascend Wellness Holdings (AAWH) United States $0.204B 0.00
Biodesix (BDSX) United States $0.189B 0.00
So-Young (SY) China $0.111B 53.49
Pono Capital Two (PTWO) United States $0.068B 0.00
NeueHealth (NEUE) United States $0.044B 5.88
Co-Diagnostics (CODX) United States $0.043B 0.00
IceCure Medical (ICCM) Israel $0.035B 0.00
Oncology Institute (TOI) United States $0.031B 0.00
Nutex Health (NUTX) United States $0.029B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.025B 0.00
SeaStar Medical Holding (ICU) United States $0.024B 0.00
Singular Genomics Systems (OMIC) United States $0.023B 0.00
OncoCyte (OCX) United States $0.022B 0.00
KindlyMD (KDLY) $0.018B 0.00
BIMI Holdings (BIMI) United States $0.015B 0.00
TRxADE HEALTH (MEDS) United States $0.012B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
XWELL (XWEL) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
ISpecimen (ISPC) United States $0.005B 0.00
DermTech (DMTK) United States $0.004B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
OpGen (OPGN) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00